Clinical trials
Observational Sarcoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Unknown status | 4 |
| Completed | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Istituto Ortopedico Rizzoli | 4 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2 |
| Italian Sarcoma Group | 2 |
| Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| European Institute of Oncology | 1 |
| Fondazione Policlinico Universitario Campus Bio-Medico | 1 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| National Cancer Institute, Naples | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 17 |
| Soft Tissue Neoplasms | 4 |
| Bone Neoplasms | 1 |
| Disease | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Hemangioendothelioma, Epithelioid | 1 |
| Hypersensitivity | 1 |
| Neoplasms | 1 |
| Neoplasms by Histologic Type | 1 |
| Neoplasms, Connective and Soft Tissue | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.